★
Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads: coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

Guided View
New to markets (prices, yields, YTD, market cap)? We explain every term as you browse, in plain English. Same data, with the help built in.

Expert View
You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Manager record · ✦ curated · archived quarter

Viking Global Investors

Founded by Andreas Halvorsen · Stamford, CT · CIK 1103804 · EDGAR filings ↗

Fundamental long/short equity.

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Diff ⇄
$37.68BReported 13F value
76Positions
34.7%Top-10 weight
46.50Effective holdings
28.6%Est. turnover
+21New
−23Exits

Reported 13F portfolio value covers U.S. reportable long positions only, not cash, bonds, shorts or non-U.S. holdings. It is not assets under management.

Reported value by quarter Q2 2024 → Q2 2026
Sector exposure
Financial Services 23.8% (-3.3pp)
Consumer Cyclical 20.1% (+3.8pp)
Technology 15.5% (+2.4pp)
Healthcare 12.7% (-0.5pp)
Industrials 8.7% (+1.0pp)
Basic Materials 7.8% (+0.6pp)
Communication Services 7.7% (-0.9pp)
Real Estate 3.7% (+0.8pp)

Share of reported common-equity value; (±pp) vs prior quarter.

The portfolio · Q4 2025
#SecurityWeightValueSharesΔ sharesHeld
1 MSFT Microsoft Corporation 4.1% $1.56B 3.22M +32.5% ▲ Add 2
2 PNC The PNC Financial Services… 4.0% $1.52B 7.29M -8.4% ▼ Trim 3
3 TSM Taiwan Semiconductor… 4.0% $1.49B 4.91M +24.6% ▲ Add 5
4 V Visa Inc. 3.7% $1.40B 3.98M +37.5% ▲ Add 6
5 SCHW The Charles Schwab… 3.7% $1.39B 13.87M -16.3% ▼ Trim 6
6 DIS The Walt Disney Company 3.4% $1.27B 11.19M +7.1% ▲ Add 3
7 APD Air Products and Chemicals… 3.1% $1.18B 4.78M +30.4% ▲ Add 3
8 MCD McDonald's Corporation 2.9% $1.11B 3.62M +7.2% ▲ Add 4
9 BBIO BridgeBio Pharma, Inc. 2.9% $1.10B 14.39M -9.9% ▼ Trim 7
10 FTV Fortive Corporation 2.8% $1.06B 19.23M -6.1% ▼ Trim 7
11 SHW The Sherwin-Williams Company 2.7% $1.03B 3.17M +10.1% ▲ Add 7
12 BA The Boeing Company 2.3% $858.29M 3.95M +31.3% ▲ Add 5
13 GOOGL Alphabet Inc. 2.2% $834.54M 2.67M New New 1
14 AMD Advanced Micro Devices, Inc. 2.1% $801.43M 3.74M -10.5% ▼ Trim 3
15 ICE Intercontinental Exchange… 2.1% $777.93M 4.80M New New 1
16 TSLA Tesla, Inc. 2.0% $764.41M 1.70M +5.6% ▲ Add 4
17 TMUS T-Mobile US, Inc. 2.0% $762.26M 3.75M +15.1% ▲ Add 7
18 AMZN Amazon.com, Inc. 1.9% $721.73M 3.13M New New 1
19 COF Capital One Financial… 1.9% $715.52M 2.95M -60.0% ▼ Trim 4
20 JCI Johnson Controls… 1.9% $708.77M 5.92M -12.9% ▼ Trim 3
21 DKNG DraftKings Inc. 1.7% $658.87M 19.12M +27.4% ▲ Add 2
22 JPM JPMorgan Chase & Co. 1.6% $614.15M 1.91M -62.3% ▼ Trim 7
23 ROST Ross Stores, Inc. 1.5% $570.59M 3.17M +56.5% ▲ Add 5
24 GM General Motors Company 1.5% $553.47M 6.81M -47.8% ▼ Trim 5
25 MAA Mid-America Apartment… 1.4% $538.98M 3.88M +46.7% ▲ Add 2
26 CPT Camden Property Trust 1.4% $524.48M 4.76M +23.9% ▲ Add 7
27 DKS DICK'S Sporting Goods, Inc. 1.4% $509.37M 2.57M New New 1
28 CLS Celestica Inc. 1.3% $502.31M 1.70M -1.4% ▼ Trim 2
29 CSX CSX Corporation 1.3% $500.89M 13.82M -13.4% ▼ Trim 7
30 ADPT Adaptive Biotechnologies… 1.3% $487.10M 29.99M 0.0% Held 7
31 SE Sea Limited 1.2% $468.38M 3.67M +20.8% ▲ Add 4
32 HCA HCA Healthcare, Inc. 1.2% $466.48M 999.18K -27.6% ▼ Trim 7
33 TMO Thermo Fisher Scientific… 1.2% $459.61M 793.19K New New 1
34 RRX Regal Rexnord Corporation 1.2% $452.38M 3.22M +3.2% ▲ Add 7
35 CVNA Carvana Co. 1.2% $447.99M 1.06M -49.5% ▼ Trim 7
36 CHWY Chewy, Inc. 1.2% $447.39M 13.54M +146.8% ▲ Add 2
37 APG APi Group Corporation 1.2% $441.43M 11.54M -6.2% ▼ Trim 7
38 STLA Stellantis N.V. 1.2% $434.32M 39.06M New New 1
39 CCL Carnival Corporation & plc 1.1% $429.45M 14.06M New New 1
40 UBS UBS Group AG 1.1% $425.96M 9.13M -30.3% ▼ Trim 3
41 UNH UnitedHealth Group… 1.0% $395.23M 1.20M New New 1
42 BMRN BioMarin Pharmaceutical Inc. 1.0% $358.78M 6.04M -27.5% ▼ Trim 7
43 SAIA Saia, Inc. 0.9% $355.44M 1.09M -21.3% ▼ Trim 3
44 TIC TIC Solutions, Inc. 0.9% $347.38M 34.36M 0.0% Held 4
45 CB Chubb Limited 0.8% $316.44M 1.01M New New 1
46 PGR The Progressive Corporation 0.8% $303.22M 1.33M New New 1
47 LII Lennox International Inc. 0.8% $301.70M 621.31K New New 1
48 TW Tradeweb Markets Inc. 0.8% $297.74M 2.77M New New 1
49 MDLN Medline Inc. 0.8% $292.28M 6.96M New New 1
50 AON Aon plc 0.7% $276.53M 783.65K -44.6% ▼ Trim 2
51 AJG Arthur J. Gallagher & Co. 0.7% $269.39M 1.04M New New 1
52 BAC Bank of America Corporation 0.7% $247.20M 4.49M -60.9% ▼ Trim 6
53 BSX Boston Scientific… 0.6% $239.31M 2.51M -5.0% ▼ Trim 6
54 DLR Digital Realty Trust, Inc. 0.6% $233.30M 1.51M New New 1
55 LOW Lowe's Companies, Inc. 0.6% $219.95M 912.04K New New 1
56 FIG Figma, Inc. 0.6% $214.97M 5.75M New New 1
57 ITUB Itaú Unibanco Holding S.A. 0.5% $203.32M 28.40M New New 1
58 AS Amer Sports, Inc. 0.5% $179.81M 4.81M -24.1% ▼ Trim 4
59 RAL Ralliant Corp 0.4% $161.01M 3.16M -37.8% ▼ Trim 3
60 RIOT Riot Platforms, Inc. 0.4% $157.47M 12.43M New New 1
61 NEWAMSTERDAM PHARMA COMPANY (unmapped) n/a $147.46M 4.20M n/a n/a
62 ROIV Roivant Sciences Ltd. 0.4% $139.82M 6.44M -72.7% ▼ Trim 7
63 IQV IQVIA Holdings Inc. 0.4% $139.58M 619.24K New New 1
64 SION Sionna Therapeutics, Inc. 0.3% $131.45M 3.20M 0.0% Held 4
65 INBX Inhibrx Biosciences Inc. 0.3% $113.58M 1.44M -19.6% ▼ Trim 7
66 PHARVARIS N V (unmapped) n/a $101.38M 3.65M n/a n/a
67 CSGP CoStar Group, Inc. 0.3% $97.00M 1.44M -22.0% ▼ Trim 3
68 WST West Pharmaceutical… 0.2% $81.17M 295.03K New New 1
69 ORKA Oruka Therapeutics, Inc. 0.2% $80.83M 2.67M 0.0% Held 2
70 LAB Standard BioTools Inc. 0.2% $75.07M 58.65M 0.0% Held 7
71 MASI Masimo Corporation 0.2% $66.90M 514.34K -52.1% ▼ Trim 3
72 ORIC ORIC Pharmaceuticals, Inc. 0.1% $53.76M 6.57M 0.0% ▼ Trim 7
73 TRVI Trevi Therapeutics, Inc. 0.1% $40.05M 3.20M -37.6% ▼ Trim 7
74 DNA Ginkgo Bioworks Holdings… 0.1% $29.73M 3.58M 0.0% Held 7
75 PEPG PEPGEN INC 0.1% $22.67M 3.48M 0.0% Held 7
76 RLYB RALLYBIO CORP 0.0% $2.88M 4.19M 0.0% Held 7

Common-stock (SH) positions only; option lines are in the Options tab and are never netted. ✂ = change computed against split-adjusted prior shares. “Held N+” = held every quarter in our window, possibly longer.

Position age
210–1 quarters
242–4 quarters
295–8 quarters

Consecutive quarters each current position has been reported, within our data window.

Similar managers
ManagerCommon positionsName overlapWeighted similarity
Soroban Capital Partners LP 5 4.8% 0.363 Compare ⇄
Brown Advisory Inc 54 3.7% 0.3537 Compare ⇄
Sanders Capital, LLC 8 6.3% 0.3376 Compare ⇄
ValueAct Capital 3 3.0% 0.3246 Compare ⇄
Dodge & Cox 24 8.4% 0.3198 Compare ⇄
Clearbridge Investments, LLC 46 6.3% 0.3112 Compare ⇄
Tiger Global Management 10 8.1% 0.3083 Compare ⇄
Ninety One UK Ltd 25 7.5% 0.298 Compare ⇄

Similarity of reported longs only; hedges and non-13F assets are invisible. Methodology

Filing record
Aug 14 2026 13F-HR · period Q2 2026

$35.08B · 90 holdings listed · View original SEC filing ↗

May 15 2026 13F-HR · period Q1 2026

$35.75B · 77 holdings listed · View original SEC filing ↗

Feb 17 2026 13F-HR · period Q4 2025

$37.68B · 76 holdings listed · View original SEC filing ↗

Nov 14 2025 13F-HR · period Q3 2025

$38.50B · 78 holdings listed · View original SEC filing ↗

Aug 14 2025 13F-HR · period Q2 2025

$34.59B · 83 holdings listed · View original SEC filing ↗

May 15 2025 13F-HR · period Q1 2025

$31.48B · 91 holdings listed · View original SEC filing ↗

Feb 14 2025 13F-HR · period Q4 2024

$30.90B · 86 holdings listed · View original SEC filing ↗

Nov 14 2024 13F-HR · period Q3 2024

$27.44B · 83 holdings listed · View original SEC filing ↗

Aug 14 2024 13F-HR · period Q2 2024

$26.02B · 82 holdings listed · View original SEC filing ↗

Provenance: All holdings parsed from this manager's 13F information tables on SEC EDGAR; values as reported, whole USD. Changes compare the latest accepted version of each quarter (amendments incorporated) on split-adjusted share counts. Reporting period: Q4 2025 · latest filing Aug 14, 2026 · Change methodology